Invoy Technologies was founded by Dr. Lubna Ahmad and is headquartered in Chandler, Arizona. Invoy is developing a hand-held device that measures multiple analytes in human breath. At Invoy, human breath is viewed as a noninvasive portal to understanding the workings of the human body. We believe the market exists for a user-friendly tool, conducive to home monitoring, that aids in disease screening and management. Our dedicated team of medical device professionals is actively working to make this a reality.
Management Team
Dr. Ahmad has spent nearly a decade innovating and developing medical devices with an emphasis on biosensor technologies. She founded Invoy to commercialize and build upon her novel designs. Having recruited an experienced and diversified team and raising necessary investment capital, Dr. Ahmad has managed the company through the development phase, executed a series of partnerships and intellectual property transactions, and positioned the company for product launch. Her experiences in sensor development and clinical study protocol design have been key in Invoy’s ability to successfully execute a demanding product development program. Dr. Ahmad also serves as an advisor to a molecular diagnostics company and is a frequent presenter at biotechnology seminars and conferences. Prior to founding Invoy, Dr. Ahmad was a fellow of the National Science Foundation. Dr. Ahmad holds a Ph.D. in biomedical engineering from Arizona State University where she was a Goldwater Scholar.
Ms. Adkisson has 25 years of experience in the medical device industry launching new products, creating and executing innovative medical marketing campaigns, and strategically repositioning mature products. Her unique skills in early stage market introduction, identification of market expansion opportunities, and business development have made her a key asset to Invoy. In addition to her experience at large corporations like Baxter and ConMed, Ms. Adkisson also worked as an integral team member of several startups. She has hands-on experience in managing clinical marketing trials, business planning, trade show management, branding, investor relations, and physician relations/thought leader development including creation of white papers and marketing tools. Ms. Adkisson holds an MBA from Pepperdine University and graduated summa cum laude from UC Irvine.
Dr. Hartzfeld has 20 years experience working in FDA-regulated industries, including medical devices. Her experience includes quality system development and implementation, laboratory controls, regulatory affairs, cGMP training, PAI readiness, and FDA 483 warning letter response writing. Dr. Hartzeld has diverse experience with both large corporations and small pre-revenue companies. Dr. Hartzfeld has a Ph.D. in chemistry, and a strong technical background in analytical chemistry and organic synthesis.
Mr. Heaton has close to 30 years of industry experience with technology and engineering companies. Mr. Heaton has substantial experience in developing electronic and hardware systems and is well versed in the manufacturing process, including design for manufacturing, design verification, and field testing. In addition to managing large product teams, he has developed several products and has taken them through manufacturing and into the market. He received his B.S.E.E. from University of Utah in 1980 with an emphasis in digital design and computer architecture.
Advisory Board
Dr. Gavin graduated from Livingstone College in Salisbury, N.C., in 1966 with a degree in chemistry. He earned his Ph.D. in biochemistry from Emory University in 1970 and his M.D. degree from Duke University School of Medicine in 1975.
Dr. Gavin is Clinical Professor of Medicine, Emory University School of Medicine, Atlanta, GA and Clinical Professor of Medicine, Indiana University School of Medicine. He was president of the Morehouse School of Medicine, Atlanta, GA from 2002-2004. He served as senior scientific officer at the Howard Hughes Medical Institute (HHMI) from 1991-2002 and director of the HHMI-National Institutes of Health Research Scholars Program from 2000-2002.
Dr. Gavin belongs to a number of organizations, including the Institute of Medicine of the National Academy of Sciences, the American Diabetes Association, the American Society of Clinical Investigation, and the American Association of Physicians. He is a past president of the American Diabetes Association and was voted Clinician of the Year by ADA in Diabetes in 1991. He is a member of the Board of Baxter International, Inc., Amylin Pharmaceuticals, and Nuvelo Pharmaceuticals, Inc. Dr. Gavin is immediate past chairman of the National Diabetes Education Program and a past member of the Advisory Council to the NIDDK. He is also chairman of the Data Safety Monitoring Board for the VA Cooperative Diabetes Study.
Dr. Kiron has over 20 years of experience in the pharmaceutical and healthcare industry and is well versed in all aspects of drug discovery, delivery, pre-clinical and early clinical drug development, bioinformatics and database management investment due-diligence, and alliance management. Prior to joining Adjuvant Global Advisors, Dr. Kiron was the Chief Operating Officer at LifeTech Innovations, LLC, a Business Development and Strategic Advisory consulting firm. Before LTI, he was the Executive Director for New Technology Assessment and Planning at Johnson & Johnson / ALZA Corporation. Responsibilities included: drug delivery technology & research strategy and planning, in- and out- licensing, M&A and intellectual property management.
Prior to his tenure at Pfizer, Dr. Kiron was a biochemistry and medicine faculty member at Cornell University Medical Center in New York. He holds a BSc in Chemistry and an MSc in Microbiology from Bombay University, India. He also earned a PhD in Biochemistry from the Indian Institute of Science in Bangalore, India and an MBA from Rensselaer in Hartford, Connecticut.
Dr. Kundu was in the employ of Abbot Labs for 23 years in medical diagnostics research and development as a Project and Lab Manager. While at Abbott, Dr. Kundu led Abbott’s team to develop and obtain FDA approval for a benchtop breath acetone device. Dr. Kundu was inducted as a Volweiler Research Fellow with eight US patents and 65 publications in books and journals. He has served as a World Health Organization Consultant in Immunodiagnostics and enjoyed nine years of teaching at Baylor University and Albert Einstein College of Medicine.
Mr. Johansen has more than 15 years of professional experience working successfully with numerous enterprise customers & technology partners worldwide in sales, alliances, business development and other management capacities. He currently works on the executive management team for iPark Silicon Valley, a Korean information technology and business development center backed by the Republic of Korea responsible for creating partnerships between US and Korea technology companies. Mr. Johansen has worked in advisory or sales management positions for a number of leading global technology companies, including Tandem Computers, Compaq, HP, Samsung and others. He is also a licensed business attorney and his software & technology experience includes developing and managing early-stage companies backed by Intel, Accel, Redpoint and other investors. His educational background includes a Juris Doctorate of Law degree from the J. Reuben Clark Law School at Brigham Young University, as well as an M.B.A. in Marketing and a B.A. in Economics.